Karen Drexler is Director at RESMED INC (RMD). They have made 3 open-market trades across 2 companies since 2023, most recently 2026-06-04.
CIK 0001504699
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RMD | 10,602 | $2.5M |
| OM | 21,317 | $87K |
| DDXS | 6,500 | — |
| Total | $2.6M |
Shares reported on the most recent Form 4, priced at the 2026-06-05 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.